Merdad Parsey - Mar 10, 2022 Form 4 Insider Report for GILEAD SCIENCES, INC. (GILD)

Role
Chief Medical Officer
Signature
/s/ Amy Kim by Power of Attorney for Merdad Parsey
Stock symbol
GILD
Transactions as of
Mar 10, 2022
Transactions value $
-$203,010
Form type
4
Date filed
3/14/2022, 09:20 PM
Previous filing
Apr 13, 2022
Next filing
Jun 13, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GILD Common Stock Options Exercise +3.46K +9.3% 40.6K Mar 10, 2022 Direct F1
transaction GILD Common Stock Options Exercise +4.16K +10.24% 44.8K Mar 10, 2022 Direct F1
transaction GILD Common Stock Tax liability -$203K -3.51K -7.83% $57.92 41.3K Mar 10, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GILD Restricted Stock Unit Options Exercise -3.46K -10.77% 28.6K Mar 10, 2022 Common Stock 3.46K Direct F1, F2
transaction GILD Restricted Stock Unit Options Exercise -4.16K -14.52% 24.5K Mar 10, 2022 Common Stock 4.16K Direct F1, F3
transaction GILD Restricted Stock Unit Award +27.8K +113.74% 52.3K Mar 10, 2022 Common Stock 27.8K Direct F1, F3
transaction GILD Non-qualified Stock Option (Right to Buy) Award $0 +172K $0.00 172K Mar 10, 2022 Common Stock 172K $57.92 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
F2 The restricted stock units have a four-year vesting schedule. 25% vest on each yearly anniversary of the date of grant until fully vested.
F3 The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of grant. The balance will vest 6.25% quarterly thereafter until fully vested.
F4 The shares subject to the option have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.